Birdwatch Note Rating
2024-11-29 05:01:42 UTC - NOT_HELPFUL
Rated by Participant: 7A2D56502C5AA9B330C429DA861934DE400E079C81CB02065F3ED2560CE268C6
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details